These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9806955)

  • 1. Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro.
    Kuhnz W; Gieschen H
    Drug Metab Dispos; 1998 Nov; 26(11):1120-7. PubMed ID: 9806955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
    Witherow LE; Houston JB
    J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
    Obach RS
    Drug Metab Dispos; 1999 Nov; 27(11):1350-9. PubMed ID: 10534321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.
    Iwatsubo T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prediction of human clearance from hepatic microsomal metabolism data.
    Obach RS
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
    Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug bioavailability in humans using immobilized artificial membrane phosphatidylcholine column chromatography and in vitro hepatic metabolic clearance.
    Shin BS; Yoon CH; Balthasar JP; Choi BY; Hong SH; Kim HJ; Lee JB; Hwang SW; Yoo SD
    Biomed Chromatogr; 2009 Jul; 23(7):764-9. PubMed ID: 19296531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
    Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
    Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
    Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
    Hillesheim HG; Ritter P; Valentin U; Hobe G
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):194-202. PubMed ID: 2599018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
    Brown HS; Griffin M; Houston JB
    Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.
    De Buck SS; Sinha VK; Fenu LA; Gilissen RA; Mackie CE; Nijsen MJ
    Drug Metab Dispos; 2007 Apr; 35(4):649-59. PubMed ID: 17267621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
    Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Morita K; Kato M; Kudo T; Ito K
    Xenobiotica; 2020 Sep; 50(9):1064-1075. PubMed ID: 32125203
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of microsomal concentration on apparent intrinsic clearance: implications for scaling in vitro data.
    Kalvass JC; Tess DA; Giragossian C; Linhares MC; Maurer TS
    Drug Metab Dispos; 2001 Oct; 29(10):1332-6. PubMed ID: 11560877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
    Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
    Miners JO; Knights KM; Houston JB; Mackenzie PI
    Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.